Development and application of a fully automatic multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis

Introduction Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic and metallic nuclides on small molecules, peptides, and antib...

Full description

Saved in:
Bibliographic Details
Published inAnnals of nuclear medicine Vol. 38; no. 4; pp. 247 - 263
Main Authors Cui, Fang-Bo, Lv, Xuan, Yan, Cheng-Long, Eng, Wai-Si, Yu, Shan-You, Zheng, Qi-Huang
Format Journal Article
LanguageEnglish
Published Singapore Springer Nature Singapore 01.04.2024
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Introduction Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic and metallic nuclides on small molecules, peptides, and antibody drugs. This study aimed to develop and test a full-automatic multifunctional module system for the safe, stable, and efficient production of radiopharmaceuticals. Methods According to characteristics of labeling process of radioactive drugs, using UG and Solidworks softwares, full-automatic cassette-based synthesis module system Mortenon M1 for synthesis of radiopharmaceuticals with various radionuclides, was designed and tested. Mortenon M1 has at least three significant highlights: the cassettes are disposable, and there is no need of manual cleaning; the synthesis method program is flexible and can be edited freely by users according to special needs; this module system is suitable for radiolabeling of both small-molecule and macromolecular drugs, with potentially various radionuclides including 18 F, 64 Cu, 68 Ga, 89 Zr, 177 Lu, etc. By program control methods for certain drugs, Mortenon M1 was used for radiolabeling of both small-molecule drugs such as [ 68 Ga]-FAPI-46 and macromolecular drugs such as [ 89 Zr]-TROP2 antibody. Quality control assays for product purity were performed with radio-iTLC and radio-HPLC, and the radiotracers were confirmed for application in microPET imaging in xenograft tumor-bearing mouse models. Results Functional tests for Mortenon M1 module system were conducted, with [ 68 Ga]-FAPI-46 and [ 89 Zr]-TROP2 antibody as goal synthetic products, and it displayed that with the cassette modules, the preset goals could be achieved successfully. The radiolabeling synthesis yield was good ([ 68 Ga]-FAPI-46, 70.63% ± 2.85%, n  = 10; [ 89 Zr]-TROP2, 82.31% ± 3.92%, n  = 10), and the radiochemical purity via radio-iTLC assay of the radiolabeled products was above 99% after purification. MicroPET imaging results showed that the radiolabeled tracers had reasonable radioactive distribution in MDA-MB-231 and SNU-620 xenograft tumor-bearing mice, and the tumor targeted radiouptake was satisfactory for diagnosis. Conclusion This study demonstrated that the full-automatic module system Mortenon M1 is efficient for radiolabeling synthesis of both small-molecule and macromolecular substrates. It may be helpful to reduce radiation exposure for safety, provide qualified radiolabeled products and reliable PET diagnosis, and ensure stable production and supply of radiopharmaceuticals.
AbstractList Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic and metallic nuclides on small molecules, peptides, and antibody drugs. This study aimed to develop and test a full-automatic multifunctional module system for the safe, stable, and efficient production of radiopharmaceuticals.INTRODUCTIONFunctions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic and metallic nuclides on small molecules, peptides, and antibody drugs. This study aimed to develop and test a full-automatic multifunctional module system for the safe, stable, and efficient production of radiopharmaceuticals.According to characteristics of labeling process of radioactive drugs, using UG and Solidworks softwares, full-automatic cassette-based synthesis module system Mortenon M1 for synthesis of radiopharmaceuticals with various radionuclides, was designed and tested. Mortenon M1 has at least three significant highlights: the cassettes are disposable, and there is no need of manual cleaning; the synthesis method program is flexible and can be edited freely by users according to special needs; this module system is suitable for radiolabeling of both small-molecule and macromolecular drugs, with potentially various radionuclides including 18F, 64Cu, 68Ga, 89Zr, 177Lu, etc. By program control methods for certain drugs, Mortenon M1 was used for radiolabeling of both small-molecule drugs such as [68Ga]-FAPI-46 and macromolecular drugs such as [89Zr]-TROP2 antibody. Quality control assays for product purity were performed with radio-iTLC and radio-HPLC, and the radiotracers were confirmed for application in microPET imaging in xenograft tumor-bearing mouse models.METHODSAccording to characteristics of labeling process of radioactive drugs, using UG and Solidworks softwares, full-automatic cassette-based synthesis module system Mortenon M1 for synthesis of radiopharmaceuticals with various radionuclides, was designed and tested. Mortenon M1 has at least three significant highlights: the cassettes are disposable, and there is no need of manual cleaning; the synthesis method program is flexible and can be edited freely by users according to special needs; this module system is suitable for radiolabeling of both small-molecule and macromolecular drugs, with potentially various radionuclides including 18F, 64Cu, 68Ga, 89Zr, 177Lu, etc. By program control methods for certain drugs, Mortenon M1 was used for radiolabeling of both small-molecule drugs such as [68Ga]-FAPI-46 and macromolecular drugs such as [89Zr]-TROP2 antibody. Quality control assays for product purity were performed with radio-iTLC and radio-HPLC, and the radiotracers were confirmed for application in microPET imaging in xenograft tumor-bearing mouse models.Functional tests for Mortenon M1 module system were conducted, with [68Ga]-FAPI-46 and [89Zr]-TROP2 antibody as goal synthetic products, and it displayed that with the cassette modules, the preset goals could be achieved successfully. The radiolabeling synthesis yield was good ([68Ga]-FAPI-46, 70.63% ± 2.85%, n = 10; [89Zr]-TROP2, 82.31% ± 3.92%, n = 10), and the radiochemical purity via radio-iTLC assay of the radiolabeled products was above 99% after purification. MicroPET imaging results showed that the radiolabeled tracers had reasonable radioactive distribution in MDA-MB-231 and SNU-620 xenograft tumor-bearing mice, and the tumor targeted radiouptake was satisfactory for diagnosis.RESULTSFunctional tests for Mortenon M1 module system were conducted, with [68Ga]-FAPI-46 and [89Zr]-TROP2 antibody as goal synthetic products, and it displayed that with the cassette modules, the preset goals could be achieved successfully. The radiolabeling synthesis yield was good ([68Ga]-FAPI-46, 70.63% ± 2.85%, n = 10; [89Zr]-TROP2, 82.31% ± 3.92%, n = 10), and the radiochemical purity via radio-iTLC assay of the radiolabeled products was above 99% after purification. MicroPET imaging results showed that the radiolabeled tracers had reasonable radioactive distribution in MDA-MB-231 and SNU-620 xenograft tumor-bearing mice, and the tumor targeted radiouptake was satisfactory for diagnosis.This study demonstrated that the full-automatic module system Mortenon M1 is efficient for radiolabeling synthesis of both small-molecule and macromolecular substrates. It may be helpful to reduce radiation exposure for safety, provide qualified radiolabeled products and reliable PET diagnosis, and ensure stable production and supply of radiopharmaceuticals.CONCLUSIONThis study demonstrated that the full-automatic module system Mortenon M1 is efficient for radiolabeling synthesis of both small-molecule and macromolecular substrates. It may be helpful to reduce radiation exposure for safety, provide qualified radiolabeled products and reliable PET diagnosis, and ensure stable production and supply of radiopharmaceuticals.
IntroductionFunctions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic and metallic nuclides on small molecules, peptides, and antibody drugs. This study aimed to develop and test a full-automatic multifunctional module system for the safe, stable, and efficient production of radiopharmaceuticals.MethodsAccording to characteristics of labeling process of radioactive drugs, using UG and Solidworks softwares, full-automatic cassette-based synthesis module system Mortenon M1 for synthesis of radiopharmaceuticals with various radionuclides, was designed and tested. Mortenon M1 has at least three significant highlights: the cassettes are disposable, and there is no need of manual cleaning; the synthesis method program is flexible and can be edited freely by users according to special needs; this module system is suitable for radiolabeling of both small-molecule and macromolecular drugs, with potentially various radionuclides including 18F, 64Cu, 68Ga, 89Zr, 177Lu, etc. By program control methods for certain drugs, Mortenon M1 was used for radiolabeling of both small-molecule drugs such as [68Ga]-FAPI-46 and macromolecular drugs such as [89Zr]-TROP2 antibody. Quality control assays for product purity were performed with radio-iTLC and radio-HPLC, and the radiotracers were confirmed for application in microPET imaging in xenograft tumor-bearing mouse models.ResultsFunctional tests for Mortenon M1 module system were conducted, with [68Ga]-FAPI-46 and [89Zr]-TROP2 antibody as goal synthetic products, and it displayed that with the cassette modules, the preset goals could be achieved successfully. The radiolabeling synthesis yield was good ([68Ga]-FAPI-46, 70.63% ± 2.85%, n = 10; [89Zr]-TROP2, 82.31% ± 3.92%, n = 10), and the radiochemical purity via radio-iTLC assay of the radiolabeled products was above 99% after purification. MicroPET imaging results showed that the radiolabeled tracers had reasonable radioactive distribution in MDA-MB-231 and SNU-620 xenograft tumor-bearing mice, and the tumor targeted radiouptake was satisfactory for diagnosis.ConclusionThis study demonstrated that the full-automatic module system Mortenon M1 is efficient for radiolabeling synthesis of both small-molecule and macromolecular substrates. It may be helpful to reduce radiation exposure for safety, provide qualified radiolabeled products and reliable PET diagnosis, and ensure stable production and supply of radiopharmaceuticals.
Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic and metallic nuclides on small molecules, peptides, and antibody drugs. This study aimed to develop and test a full-automatic multifunctional module system for the safe, stable, and efficient production of radiopharmaceuticals. According to characteristics of labeling process of radioactive drugs, using UG and Solidworks softwares, full-automatic cassette-based synthesis module system Mortenon M1 for synthesis of radiopharmaceuticals with various radionuclides, was designed and tested. Mortenon M1 has at least three significant highlights: the cassettes are disposable, and there is no need of manual cleaning; the synthesis method program is flexible and can be edited freely by users according to special needs; this module system is suitable for radiolabeling of both small-molecule and macromolecular drugs, with potentially various radionuclides including F, Cu, Ga, Zr, Lu, etc. By program control methods for certain drugs, Mortenon M1 was used for radiolabeling of both small-molecule drugs such as [ Ga]-FAPI-46 and macromolecular drugs such as [ Zr]-TROP2 antibody. Quality control assays for product purity were performed with radio-iTLC and radio-HPLC, and the radiotracers were confirmed for application in microPET imaging in xenograft tumor-bearing mouse models. Functional tests for Mortenon M1 module system were conducted, with [ Ga]-FAPI-46 and [ Zr]-TROP2 antibody as goal synthetic products, and it displayed that with the cassette modules, the preset goals could be achieved successfully. The radiolabeling synthesis yield was good ([ Ga]-FAPI-46, 70.63% ± 2.85%, n = 10; [ Zr]-TROP2, 82.31% ± 3.92%, n = 10), and the radiochemical purity via radio-iTLC assay of the radiolabeled products was above 99% after purification. MicroPET imaging results showed that the radiolabeled tracers had reasonable radioactive distribution in MDA-MB-231 and SNU-620 xenograft tumor-bearing mice, and the tumor targeted radiouptake was satisfactory for diagnosis. This study demonstrated that the full-automatic module system Mortenon M1 is efficient for radiolabeling synthesis of both small-molecule and macromolecular substrates. It may be helpful to reduce radiation exposure for safety, provide qualified radiolabeled products and reliable PET diagnosis, and ensure stable production and supply of radiopharmaceuticals.
Introduction Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic and metallic nuclides on small molecules, peptides, and antibody drugs. This study aimed to develop and test a full-automatic multifunctional module system for the safe, stable, and efficient production of radiopharmaceuticals. Methods According to characteristics of labeling process of radioactive drugs, using UG and Solidworks softwares, full-automatic cassette-based synthesis module system Mortenon M1 for synthesis of radiopharmaceuticals with various radionuclides, was designed and tested. Mortenon M1 has at least three significant highlights: the cassettes are disposable, and there is no need of manual cleaning; the synthesis method program is flexible and can be edited freely by users according to special needs; this module system is suitable for radiolabeling of both small-molecule and macromolecular drugs, with potentially various radionuclides including 18 F, 64 Cu, 68 Ga, 89 Zr, 177 Lu, etc. By program control methods for certain drugs, Mortenon M1 was used for radiolabeling of both small-molecule drugs such as [ 68 Ga]-FAPI-46 and macromolecular drugs such as [ 89 Zr]-TROP2 antibody. Quality control assays for product purity were performed with radio-iTLC and radio-HPLC, and the radiotracers were confirmed for application in microPET imaging in xenograft tumor-bearing mouse models. Results Functional tests for Mortenon M1 module system were conducted, with [ 68 Ga]-FAPI-46 and [ 89 Zr]-TROP2 antibody as goal synthetic products, and it displayed that with the cassette modules, the preset goals could be achieved successfully. The radiolabeling synthesis yield was good ([ 68 Ga]-FAPI-46, 70.63% ± 2.85%, n  = 10; [ 89 Zr]-TROP2, 82.31% ± 3.92%, n  = 10), and the radiochemical purity via radio-iTLC assay of the radiolabeled products was above 99% after purification. MicroPET imaging results showed that the radiolabeled tracers had reasonable radioactive distribution in MDA-MB-231 and SNU-620 xenograft tumor-bearing mice, and the tumor targeted radiouptake was satisfactory for diagnosis. Conclusion This study demonstrated that the full-automatic module system Mortenon M1 is efficient for radiolabeling synthesis of both small-molecule and macromolecular substrates. It may be helpful to reduce radiation exposure for safety, provide qualified radiolabeled products and reliable PET diagnosis, and ensure stable production and supply of radiopharmaceuticals.
Author Cui, Fang-Bo
Lv, Xuan
Yan, Cheng-Long
Eng, Wai-Si
Zheng, Qi-Huang
Yu, Shan-You
Author_xml – sequence: 1
  givenname: Fang-Bo
  surname: Cui
  fullname: Cui, Fang-Bo
  organization: Department of Oncology, The People’s Hospital of Ma Anshan
– sequence: 2
  givenname: Xuan
  surname: Lv
  fullname: Lv, Xuan
  organization: Norroy Bioscience Co., Ltd
– sequence: 3
  givenname: Cheng-Long
  surname: Yan
  fullname: Yan, Cheng-Long
  organization: Norroy Bioscience Co., Ltd
– sequence: 4
  givenname: Wai-Si
  surname: Eng
  fullname: Eng, Wai-Si
  organization: Norroy Bioscience Co., Ltd
– sequence: 5
  givenname: Shan-You
  surname: Yu
  fullname: Yu, Shan-You
  email: yushanyou@norroybioscience.com
  organization: Norroy Bioscience Co., Ltd
– sequence: 6
  givenname: Qi-Huang
  surname: Zheng
  fullname: Zheng, Qi-Huang
  email: qzheng@iupui.edu
  organization: Department of Radiology and Imaging Sciences, Indiana University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38145430$$D View this record in MEDLINE/PubMed
BookMark eNp90U1rFTEUBuAgFXtb_QMuJOCmm9F8TSZZSq2t0NJNXQ-ZzImdkknGfAh34X839lYFF64C4XlPDnlP0FGIARB6Tck7SsjwPlNGhe4I4x2hSvOOPUM7qqTopOD8CO2IpqIbqBqO0UnOD4Qw1Sv2Ah1zRUUvONmhHx_hO_i4rRAKNmHGZtv8Yk1ZYsDRYYNd9X6PTS1xbbcWr9WXpXM12EdjTc5QCuA1ztUDvompQFsU31DsYsLJzEvc7k1ajYXaBhiP8z6Ue8hLfomeO-MzvHo6T9GXTxd351fd9e3l5_MP153lPSmdnIDSQTsyTJNg1BIpiGZiBpDUcuIc0bMUDiyd1GSN7jntZwW9U1Jr3Vt-is4Oc7cUv1XIZVyXbMF7EyDWPDJN-kFRqVWjb_-hD7Gm0LZramADk0zSpt48qTqtMI9bWlaT9uPvj22AHYBNMecE7g-hZPzV3nhob2ztjY_tjayF-CGUGw5fIf19-z-pn-Jznd0
Cites_doi 10.1016/j.apradiso.2020.109468
10.1002/jlcr.3706
10.1007/s00259-021-05563-1
10.18893/kakuigaku.oa.1802
10.1016/j.apradiso.2012.03.006
10.1186/s41181-019-0077-0
10.1039/d2re00219arsc.li/reaction-engineering
10.1039/d1lc00148e
10.1016/j.apradiso.2012.09.010
10.3390/ijms20225579
10.3390/ph10040077
10.1186/2191-219X-3-52
10.1620/tjem.211.379
10.2967/jnumed.113.132472
10.1002/jlcr.1865
10.1186/s41181-022-00172-1
10.1186/s41181-020-00095-9
10.1002/jlcr.1937
10.1038/nprot.2016.060
10.2174/1389450117666160720091233
10.1007/s00259-021-05266-7
10.1016/j.ijpharm.2014.01.034
10.1016/j.apradiso.2017.02.030
10.1016/j.apradiso.2006.06.016
10.3791/63025
10.1007/978-3-540-49527-7_11
10.1016/j.nucmedbio.2014.12.010
10.1016/j.apradiso.2010.06.023
10.1016/j.apradiso.2016.02.016
10.1136/jitc-2022-004848
10.1016/j.apradiso.2013.05.009
10.1186/s41181-016-0018-0
10.3390/molecules27030675
ContentType Journal Article
Copyright The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2023. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine.
Copyright_xml – notice: The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2023. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
K9.
NAPCQ
7X8
DOI 10.1007/s12149-023-01893-2
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1864-6433
EndPage 263
ExternalDocumentID 38145430
10_1007_s12149_023_01893_2
Genre Journal Article
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.55
.86
.VR
06C
06D
0R~
0VY
1N0
2.D
203
23M
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2WC
2~H
30V
3V.
4.4
406
408
40D
40E
53G
5GY
5VS
67Z
6J9
6NX
7RV
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
8G5
8TC
8UJ
8WZ
95-
95.
95~
96X
A6W
AAAVM
AABHQ
AACDK
AAEWM
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACDTI
ACGFO
ACGFS
ACHSB
ACHXU
ACIHN
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACREN
ACSNA
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEAQA
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARAPS
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BAWUL
BBNVY
BBWZM
BDATZ
BENPR
BGLVJ
BGNMA
BHPHI
BKEYQ
BPHCQ
BVXVI
C1A
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DIK
DNIVK
DPUIP
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
EX3
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRP
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GRRUI
GUQSH
GX1
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HRMNR
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXD
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
KPH
LK8
LLZTM
M1P
M2O
M4Y
M7P
MA-
N9A
NAPCQ
NDZJH
NF0
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P2P
P62
P6G
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RNS
ROL
RPX
RSV
S16
S1Z
S27
S37
S3B
SAP
SCLPG
SDE
SDH
SHX
SISQX
SJN
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TEORI
TKC
TR2
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W2D
W48
WJK
WK8
WOW
X7M
XSB
YLTOR
Z45
Z7U
Z7X
Z82
Z83
Z87
Z8O
Z8V
Z91
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
OVT
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7QP
7TK
K9.
7X8
ID FETCH-LOGICAL-c350t-6be1179f07bb421c0640924dee61c30ff09d64fec1b8bca95315d8e5f869995c3
IEDL.DBID U2A
ISSN 0914-7187
1864-6433
IngestDate Thu Jul 10 23:38:13 EDT 2025
Fri Jul 25 19:14:54 EDT 2025
Mon Jul 21 05:57:11 EDT 2025
Tue Jul 01 02:35:02 EDT 2025
Fri Feb 21 02:39:33 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Automatic module
Ga]-FAPI-46
Zr]-TROP2 antibody
[
Radiopharmaceuticals
Labeling synthesis
[89Zr]-TROP2 antibody
[68Ga]-FAPI-46
Language English
License 2023. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c350t-6be1179f07bb421c0640924dee61c30ff09d64fec1b8bca95315d8e5f869995c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 38145430
PQID 2972726261
PQPubID 54108
PageCount 17
ParticipantIDs proquest_miscellaneous_2905781698
proquest_journals_2972726261
pubmed_primary_38145430
crossref_primary_10_1007_s12149_023_01893_2
springer_journals_10_1007_s12149_023_01893_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-04-01
PublicationDateYYYYMMDD 2024-04-01
PublicationDate_xml – month: 04
  year: 2024
  text: 2024-04-01
  day: 01
PublicationDecade 2020
PublicationPlace Singapore
PublicationPlace_xml – name: Singapore
– name: Japan
– name: Tokyo
PublicationTitle Annals of nuclear medicine
PublicationTitleAbbrev Ann Nucl Med
PublicationTitleAlternate Ann Nucl Med
PublicationYear 2024
Publisher Springer Nature Singapore
Springer Nature B.V
Publisher_xml – name: Springer Nature Singapore
– name: Springer Nature B.V
References Da Pieve, Costa Braga, Turton, Valla, Cakmak, Plate (CR9) 2022; 27
Cardinale, Martin, Remde, Schäfer, Hienzsch, Hübner (CR11) 2017; 10
Hoareau, Shao, Henderson, Scott (CR25) 2012; 70
Garcia-Arguello, Lopez-Lorenzo, Ruiz-Cruces (CR35) 2019; 62
CR16
Boschi, Lodi, Malizia, Cicoria, Marengo (CR34) 2013; 76
Zaheer, Kim, Lee, Kim, Lim (CR2) 2019; 20
Nakamura, Matsumura, Yamamoto, Senda (CR12) 2019; 56
Oh, Chi, Mosdzianowski, Kil, Ryu, Moon (CR23) 2007; 65
Yue, Nikam, Kecskemethy, Kandula, Falchek, Averill (CR8) 2021
Ovdiichuk, Mallapura, Pineda, Hourtané, Långström, Halldin (CR24) 2021; 21
Wang, Chuang, Chiu, Cham, Chung (CR4) 2007; 211
Shao, Hoareau, Runkle, Tluczek, Hockley, Henderson, Scott (CR30) 2011; 54
Cagnolini, Chen, Ramos, Skedzielewski, Lantry, Nunn (CR17) 2010; 68
Krasikova (CR31) 2007; 62
Li, Schmitz, Lee, Mach (CR28) 2017; 1
Ferdinandus, Kessler, Hirmas, Trajkovic-Arsic, Hamacher, Umutlu (CR14) 2021; 48
Shao, Hoareau, Hockley, Tluczek, Henderson, Padgett, Scott (CR29) 2011; 54
Aalbersberg, van Andel, Geluk-Jonker, Beijnen, Stokkel, Hendrikx (CR21) 2020; 5
Toyohara, Nishino, Sakai, Tago, Oda (CR7) 2021; 168
Frank, Winter, Rensei, Samper, Brooks, Hockley, Henderson, Rensch, Scott (CR32) 2019; 4
Sun, Henry, Laville, Carré, Hamaoui, Bockel (CR1) 2022; 10
Schwarz, Dick, VanBrocklin, Hoffman (CR22) 2014; 55
Mueller, Breeman, Klette, Gottschaldt, Odparlik, Baehre (CR13) 2016; 11
Lazari, Quinn, Claggett, Collins, Shah, Herman (CR18) 2013; 3
Patt, Schildan, Habermann, Fischer, Hiller, Deuther-Conrad (CR10) 2013; 80
Sharma (CR6) 2016; 17
Zhang, Basuli, Shi, Xu, Blackman, Choyke (CR26) 2016; 112
Bruton, Scott (CR27) 2020
ter Heine, Lange, Breukels, Bloemendal, Rummenie, Wakker (CR3) 2014; 465
Chen, Li, Younis, Barnhart, Jiang, Sun (CR15) 2022; 49
Alfteimi, Lützen, Helm, Jüptner, Marx, Zhao (CR20) 2022; 7
Revunov, Jørgensen, Jensen, Hansen, Severin, Kjær (CR5) 2015; 42
Barnes, Nair, Aboagye, Archibald, Allott (CR33) 2022; 7
Liu, Nie, Jiang, Tang (CR19) 2017; 123
R ter Heine (1893_CR3) 2014; 465
YF Wang (1893_CR4) 2007; 211
C Frank (1893_CR32) 2019; 4
J Ferdinandus (1893_CR14) 2021; 48
J Zaheer (1893_CR2) 2019; 20
J Toyohara (1893_CR7) 2021; 168
S Liu (1893_CR19) 2017; 123
X Shao (1893_CR30) 2011; 54
O Ovdiichuk (1893_CR24) 2021; 21
T Nakamura (1893_CR12) 2019; 56
M Patt (1893_CR10) 2013; 80
S Boschi (1893_CR34) 2013; 76
X Yue (1893_CR8) 2021
D Mueller (1893_CR13) 2016; 11
J Cardinale (1893_CR11) 2017; 10
EA Aalbersberg (1893_CR21) 2020; 5
SJ Oh (1893_CR23) 2007; 65
X Shao (1893_CR29) 2011; 54
R Sun (1893_CR1) 2022; 10
E Revunov (1893_CR5) 2015; 42
R Krasikova (1893_CR31) 2007; 62
SW Schwarz (1893_CR22) 2014; 55
C Da Pieve (1893_CR9) 2022; 27
S Sharma (1893_CR6) 2016; 17
A Alfteimi (1893_CR20) 2022; 7
SF Garcia-Arguello (1893_CR35) 2019; 62
1893_CR16
R Hoareau (1893_CR25) 2012; 70
L Bruton (1893_CR27) 2020
W Chen (1893_CR15) 2022; 49
M Lazari (1893_CR18) 2013; 3
S Li (1893_CR28) 2017; 1
C Barnes (1893_CR33) 2022; 7
A Cagnolini (1893_CR17) 2010; 68
X Zhang (1893_CR26) 2016; 112
References_xml – volume: 168
  year: 2021
  ident: CR7
  article-title: Automated production of [18F]MK-6240 on CFN-MPS200
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2020.109468
– volume: 62
  start-page: 146
  issue: 3
  year: 2019
  end-page: 153
  ident: CR35
  article-title: Automated production of [ Ga]Ga-DOTANOC and [ Ga]Ga-PSMA-11 using a TRACERlab FXFN synthesis module
  publication-title: J Labelled Comp Radiopharm
  doi: 10.1002/jlcr.3706
– volume: 49
  start-page: 861
  issue: 3
  year: 2022
  end-page: 870
  ident: CR15
  article-title: ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-021-05563-1
– volume: 56
  start-page: 127
  issue: 1
  year: 2019
  end-page: 134
  ident: CR12
  article-title: Safety and effectiveness of NEPTIS Plug-01 and Florbetapir ( F) in daily clinical setting: based on the post-marketing surveillance study
  publication-title: Kaku Igaku
  doi: 10.18893/kakuigaku.oa.1802
– volume: 70
  start-page: 1779
  issue: 8
  year: 2012
  end-page: 1783
  ident: CR25
  article-title: Fully automated radiosynthesis of [ C]PBR28, a radiopharmaceutical for the translocator protein (TSPO) 18 kDa, using a GE TRACERlab FXC-Pro
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2012.03.006
– volume: 4
  start-page: 24
  issue: 1
  year: 2019
  ident: CR32
  article-title: Development and implementation of ISAR, a new synthesis platform for radiopharmaceutical production
  publication-title: EJNMMI Radiopharm Chem
  doi: 10.1186/s41181-019-0077-0
– volume: 7
  start-page: 2265
  year: 2022
  end-page: 2279
  ident: CR33
  article-title: A practical guide to automating fluorine-18 PET radiochemistry using commercially available cassette-based platforms
  publication-title: React Chem Eng
  doi: 10.1039/d2re00219arsc.li/reaction-engineering
– volume: 21
  start-page: 2272
  issue: 11
  year: 2021
  end-page: 2282
  ident: CR24
  article-title: Implementation of iMiDEV™, a new fully automated microfluidic platform for radiopharmaceutical production
  publication-title: Lab Chip
  doi: 10.1039/d1lc00148e
– ident: CR16
– year: 2020
  ident: CR27
  article-title: Automated synthesis modules for PET radiochemistry
  publication-title: Handbook of radiopharmaceuticals
– volume: 76
  start-page: 38
  year: 2013
  end-page: 45
  ident: CR34
  article-title: Automation synthesis modules review
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2012.09.010
– volume: 20
  start-page: 5579
  issue: 22
  year: 2019
  ident: CR2
  article-title: Combination radioimmunotherapy strategies for solid tumors
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20225579
– volume: 10
  start-page: 77
  issue: 4
  year: 2017
  ident: CR11
  article-title: Procedures for the GMP-compliant production and quality control of [ F]PSMA-1007: a next generation radiofluorinated tracer for the detection of prostate cancer
  publication-title: Pharmaceuticals (Basel)
  doi: 10.3390/ph10040077
– volume: 3
  start-page: 52
  issue: 1
  year: 2013
  ident: CR18
  article-title: ELIXYS - a fully automated, three-reactor high-pressure radiosynthesizer for development and routine production of diverse PET tracers
  publication-title: EJNMMI Res
  doi: 10.1186/2191-219X-3-52
– volume: 211
  start-page: 379
  issue: 4
  year: 2007
  end-page: 385
  ident: CR4
  article-title: On-site preparation of technetium-99m labeled human serum albumin for clinical application
  publication-title: Tohoku J Exp Med
  doi: 10.1620/tjem.211.379
– volume: 55
  start-page: 1132
  issue: 7
  year: 2014
  end-page: 1137
  ident: CR22
  article-title: Regulatory requirements for PET drug production
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.113.132472
– volume: 54
  start-page: 292
  issue: 6
  year: 2011
  end-page: 307
  ident: CR29
  article-title: Highlighting the versatility of the tracerlab synthesis modules. Part 1: fully automated production of [F]labelled radiopharmaceuticals using a Tracerlab FX(FN)
  publication-title: J Labelled Comp Radiopharm.
  doi: 10.1002/jlcr.1865
– volume: 7
  start-page: 20
  issue: 1
  year: 2022
  ident: CR20
  article-title: Automated synthesis of [ Ga]Ga-FAPI-46 without pre-purification of the generator eluate on three common synthesis modules and two generator types
  publication-title: EJNMMI Radiopharm Chem
  doi: 10.1186/s41181-022-00172-1
– volume: 5
  start-page: 10
  issue: 1
  year: 2020
  ident: CR21
  article-title: Automated synthesis and quality control of [ Tc]Tc-PSMA for radioguided surgery (in a [ Ga]Ga-PSMA workflow)
  publication-title: EJNMMI Radiopharm Chem
  doi: 10.1186/s41181-020-00095-9
– volume: 54
  start-page: 819
  year: 2011
  end-page: 838
  ident: CR30
  article-title: Highlighting the versatility of the Tracerlab synthesis modules. Part 2: fully automated production of [11C]-labeled radiopharmaceuticals using a Tracerlab FXC-Pro
  publication-title: J Label Compd Radiopharm
  doi: 10.1002/jlcr.1937
– volume: 11
  start-page: 1057
  issue: 6
  year: 2016
  end-page: 1066
  ident: CR13
  article-title: Radiolabeling of DOTA-like conjugated peptides with generator-produced Ga and using NaCl-based cationic elution method
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2016.060
– volume: 17
  start-page: 1894
  issue: 16
  year: 2016
  end-page: 1907
  ident: CR6
  article-title: PET radiopharmaceuticals for personalized medicine
  publication-title: Curr Drug Targets
  doi: 10.2174/1389450117666160720091233
– volume: 48
  start-page: 3221
  issue: 10
  year: 2021
  end-page: 3227
  ident: CR14
  article-title: Equivalent tumor detection for early and late FAPI-46 PET acquisition
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-021-05266-7
– volume: 465
  start-page: 317
  issue: 1–2
  year: 2014
  end-page: 324
  ident: CR3
  article-title: Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2014.01.034
– volume: 123
  start-page: 49
  year: 2017
  end-page: 53
  ident: CR19
  article-title: Efficient automated synthesis of 2-(5-[ F]fluoropentyl)-2-methylmalonic acid ([ F]ML-10) on a commercial available [ F]FDG synthesis module
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2017.02.030
– volume: 65
  start-page: 676
  issue: 6
  year: 2007
  end-page: 681
  ident: CR23
  article-title: The automatic production of 16alpha-[ F]fluoroestradiol using a conventional [ F]FDG module with a disposable cassette system
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2006.06.016
– year: 2021
  ident: CR8
  article-title: Radiosynthesis of 1-(2-[ F]Fluoroethyl)-L-Tryptophan using a one-pot, two-step protocol
  publication-title: J Vis Exp
  doi: 10.3791/63025
– volume: 62
  start-page: 289
  year: 2007
  end-page: 316
  ident: CR31
  article-title: Synthesis modules and automation in F-18 labeling
  publication-title: Ernst Scher Res Found Workshop
  doi: 10.1007/978-3-540-49527-7_11
– volume: 42
  start-page: 413
  issue: 4
  year: 2015
  end-page: 419
  ident: CR5
  article-title: Automated synthesis and PET evaluation of both enantiomers of [ F]FMISO
  publication-title: Nucl Med Biol
  doi: 10.1016/j.nucmedbio.2014.12.010
– volume: 68
  start-page: 2285
  issue: 12
  year: 2010
  end-page: 2292
  ident: CR17
  article-title: Automated synthesis, characterization and biological evaluation of [(68)Ga]Ga-AMBA, and the synthesis and characterization of (nat)Ga-AMBA and [(67)Ga]Ga-AMBA
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2010.06.023
– volume: 112
  start-page: 110
  year: 2016
  end-page: 114
  ident: CR26
  article-title: Automated synthesis of [(18)F](2S,4R)-4-fluoroglutamine on a GE TRACERlab™ FX-N Pro module
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2016.02.016
– volume: 10
  issue: 7
  year: 2022
  ident: CR1
  article-title: Imaging approaches and radiomics: toward a new era of ultraprecision radioimmunotherapy?
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2022-004848
– volume: 80
  start-page: 7
  year: 2013
  end-page: 11
  ident: CR10
  article-title: Fully automated radiosynthesis of both enantiomers of [ F]Flubatine under GMP conditions for human application
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2013.05.009
– volume: 1
  start-page: 15
  issue: 1
  year: 2017
  ident: CR28
  article-title: Automation of the radiosynthesis of six different F-labeled radiotracers on the AllinOne
  publication-title: EJNMMI Radiopharm Chem
  doi: 10.1186/s41181-016-0018-0
– volume: 27
  start-page: 675
  issue: 3
  year: 2022
  ident: CR9
  article-title: New fully automated preparation of high apparent molar activity Ga-FAPI-46 on a Trasis AiO platform
  publication-title: Molecules
  doi: 10.3390/molecules27030675
– volume: 465
  start-page: 317
  issue: 1–2
  year: 2014
  ident: 1893_CR3
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2014.01.034
– volume: 3
  start-page: 52
  issue: 1
  year: 2013
  ident: 1893_CR18
  publication-title: EJNMMI Res
  doi: 10.1186/2191-219X-3-52
– volume: 10
  start-page: 77
  issue: 4
  year: 2017
  ident: 1893_CR11
  publication-title: Pharmaceuticals (Basel)
  doi: 10.3390/ph10040077
– volume: 62
  start-page: 146
  issue: 3
  year: 2019
  ident: 1893_CR35
  publication-title: J Labelled Comp Radiopharm
  doi: 10.1002/jlcr.3706
– volume: 10
  issue: 7
  year: 2022
  ident: 1893_CR1
  publication-title: J Immunother Cancer
  doi: 10.1136/jitc-2022-004848
– volume: 1
  start-page: 15
  issue: 1
  year: 2017
  ident: 1893_CR28
  publication-title: EJNMMI Radiopharm Chem
  doi: 10.1186/s41181-016-0018-0
– volume: 54
  start-page: 292
  issue: 6
  year: 2011
  ident: 1893_CR29
  publication-title: J Labelled Comp Radiopharm.
  doi: 10.1002/jlcr.1865
– volume: 68
  start-page: 2285
  issue: 12
  year: 2010
  ident: 1893_CR17
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2010.06.023
– volume: 112
  start-page: 110
  year: 2016
  ident: 1893_CR26
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2016.02.016
– volume: 76
  start-page: 38
  year: 2013
  ident: 1893_CR34
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2012.09.010
– volume: 48
  start-page: 3221
  issue: 10
  year: 2021
  ident: 1893_CR14
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-021-05266-7
– volume: 21
  start-page: 2272
  issue: 11
  year: 2021
  ident: 1893_CR24
  publication-title: Lab Chip
  doi: 10.1039/d1lc00148e
– volume: 168
  year: 2021
  ident: 1893_CR7
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2020.109468
– year: 2021
  ident: 1893_CR8
  publication-title: J Vis Exp
  doi: 10.3791/63025
– volume: 55
  start-page: 1132
  issue: 7
  year: 2014
  ident: 1893_CR22
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.113.132472
– volume: 62
  start-page: 289
  year: 2007
  ident: 1893_CR31
  publication-title: Ernst Scher Res Found Workshop
  doi: 10.1007/978-3-540-49527-7_11
– volume-title: Handbook of radiopharmaceuticals
  year: 2020
  ident: 1893_CR27
– volume: 49
  start-page: 861
  issue: 3
  year: 2022
  ident: 1893_CR15
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-021-05563-1
– volume: 70
  start-page: 1779
  issue: 8
  year: 2012
  ident: 1893_CR25
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2012.03.006
– volume: 80
  start-page: 7
  year: 2013
  ident: 1893_CR10
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2013.05.009
– volume: 5
  start-page: 10
  issue: 1
  year: 2020
  ident: 1893_CR21
  publication-title: EJNMMI Radiopharm Chem
  doi: 10.1186/s41181-020-00095-9
– volume: 211
  start-page: 379
  issue: 4
  year: 2007
  ident: 1893_CR4
  publication-title: Tohoku J Exp Med
  doi: 10.1620/tjem.211.379
– volume: 20
  start-page: 5579
  issue: 22
  year: 2019
  ident: 1893_CR2
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20225579
– volume: 27
  start-page: 675
  issue: 3
  year: 2022
  ident: 1893_CR9
  publication-title: Molecules
  doi: 10.3390/molecules27030675
– volume: 42
  start-page: 413
  issue: 4
  year: 2015
  ident: 1893_CR5
  publication-title: Nucl Med Biol
  doi: 10.1016/j.nucmedbio.2014.12.010
– volume: 7
  start-page: 2265
  year: 2022
  ident: 1893_CR33
  publication-title: React Chem Eng
  doi: 10.1039/d2re00219arsc.li/reaction-engineering
– volume: 56
  start-page: 127
  issue: 1
  year: 2019
  ident: 1893_CR12
  publication-title: Kaku Igaku
  doi: 10.18893/kakuigaku.oa.1802
– ident: 1893_CR16
– volume: 54
  start-page: 819
  year: 2011
  ident: 1893_CR30
  publication-title: J Label Compd Radiopharm
  doi: 10.1002/jlcr.1937
– volume: 11
  start-page: 1057
  issue: 6
  year: 2016
  ident: 1893_CR13
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2016.060
– volume: 123
  start-page: 49
  year: 2017
  ident: 1893_CR19
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2017.02.030
– volume: 7
  start-page: 20
  issue: 1
  year: 2022
  ident: 1893_CR20
  publication-title: EJNMMI Radiopharm Chem
  doi: 10.1186/s41181-022-00172-1
– volume: 4
  start-page: 24
  issue: 1
  year: 2019
  ident: 1893_CR32
  publication-title: EJNMMI Radiopharm Chem
  doi: 10.1186/s41181-019-0077-0
– volume: 17
  start-page: 1894
  issue: 16
  year: 2016
  ident: 1893_CR6
  publication-title: Curr Drug Targets
  doi: 10.2174/1389450117666160720091233
– volume: 65
  start-page: 676
  issue: 6
  year: 2007
  ident: 1893_CR23
  publication-title: Appl Radiat Isot
  doi: 10.1016/j.apradiso.2006.06.016
SSID ssj0028582
Score 2.3600981
Snippet Introduction Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There...
Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few...
IntroductionFunctions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 247
SubjectTerms Animal models
Animals
Antibodies
Cassettes
Chemical synthesis
Control methods
Diagnosis
Drugs
Functional testing
Gallium isotopes
Gallium Radioisotopes - chemistry
Humans
Imaging
Macromolecules
Medicine
Medicine & Public Health
Mice
Modules
Neoplasms
Nuclear Medicine
Nuclides
Original Article
Peptides
Pharmaceuticals
Production methods
Purity
Quality control
Radiation effects
Radioactive tracers
Radiochemistry
Radioisotopes
Radioisotopes - chemistry
Radiolabelling
Radiology
Radiopharmaceuticals - chemistry
Substrates
Tumors
Xenografts
Xenotransplantation
Zirconium isotopes
Title Development and application of a fully automatic multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis
URI https://link.springer.com/article/10.1007/s12149-023-01893-2
https://www.ncbi.nlm.nih.gov/pubmed/38145430
https://www.proquest.com/docview/2972726261
https://www.proquest.com/docview/2905781698
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxshEB7lIUW5VG2e26YWkXJrkRYW1uzRqvJQIvdUS85pBSwokZJdK2sfcuh_74B3bVdpDj2DADHAfMP3MQBceKNSz4eOVujcqNCZoNoOJdVecWZ4aoQP9x3jn_nNRNxO5bR7FNb2aveekown9fqxG0c0T9HHYPiLXpbiwbsrMXYPQq4JH63CLCXjF1HoCIPSUA27pzL_buNvd_QGY77hR6PbufoIHzq8SEZLA3-CLVcfwN64Y8QP4feG6ofouiIbjDRpPNEkXLC_Er2YNzE7K4kSQhr8WaxjET0HuQ95bqrFkyNRfVtjwZgRBLTkRVePzexh8-abtK814sb2sT2CydXlrx83tPtSgdpMpnOaGxdywPl0aIzgzAYeDyOwyrmc2Sz1Pi2qXHhnmVHG6gJ3qKyUk17liCSlzY5hB4fgToEwZ4zXnGO8JERhtELgkPOiwkaUskwm8K2f2XK2zJxRrnMkBzuUaIcy2qHkCZz1k192u6gteRFoYgy5WALnq2Jc_4HU0LVrFqEOIk7F8kIlcLI02qo7RCNCiixN4HtvxXXj74_l8_9V_wL7uAo7Oc8Z7MxfFu4rIpW5GcDu6Pr-7nIA29dTNojL9A9XTeLK
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1BTxQxFH5BSJSLUVEZRKmJnrTJtNPOdg4eiEoWYTmxCbex7bSBRGYIsxuyB_6NP9TX7szuEvTggXObTtPXN-97_b6-AnzwRqWeDxytMLhRoTNBtR1Iqr3izPDUCB_OO0Yn-XAsfpzJszX43d-FiWr3npKMf-rlZTeOaJ5ijMH0F6Ms5Z2U8sjNbjBRa78cfkOrfuT84Pvp1yHt3hKgNpPphObGheJnPh0YIzizgcDC1KNyLmc2S71PiyoX3llmlLG6wK0pK-WkVzlCKGkzHPcRbCD4UMF3xnx_kdYpGZ-kwsAblI1q0F3N-fuc74a_e5j2Hh8bw9zBM3ja4VOyP99Qz2HN1S_g8ahj4LfgdkVlRHRdkRUGnDSeaBIO9GdETydNrAZLomSRhvgZ-1hE60FeRC6bavrLkaj2rbFhxAgCaHKtq4vm6nz1pJ20sxpxanvRvoTxgyz7K1jHKbhtIMwZ4zXnmJ8JURitEKjkvKhwEKUskwl86le2vJpX6iiXNZmDHUq0QxntUPIEdvvFLzuvbUteBFoaUzyWwPtFM_pbIFF07Zpp6IMIV7G8UAm8nhtt8TlEP0KKLE3gc2_F5eD_nsvO_3XfgyfD09FxeXx4cvQGNjmirLmUaBfWJ9dT9xZR0sS8i5uUwM-H9oo_XC0dNQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VIlVcEOWrKS0YCU5gNXacrHPgUFFWLWUrDqzUW7BjW61UklWTVbUH_hM_kbGT7C4qHDj0HMuxPB7NG783Y4A3TsvY8ZGlBoMbFSoRVJWjlConOdM81sL5-47JWXY8FZ_P0_MN-DXUwgS1-0BJdjUNvktT1R7MjDtYFb5xRPYU4w2mwhhxKe9llad2cYNJW_Ph5Agt_Jbz8advH49p_64ALZM0bmmmrW-E5uKR1oKz0pNZmIYYazNWJrFzcW4y4WzJtNSlyvGYpkba1MkM4VRaJjjvPbgvfPUxetCUHy5TPJmG56kwCHuVoxz1ZTp_X_OfofAWvr3FzYaQN34ED3usSg67w7UNG7Z6DFuTno1_Aj_XFEdEVYasseGkdkQRf7m_IGre1qEzLAnyRepjaRhTInL3UiPyozbzK0uC8rfCDxNGEEyTa2Uu69nF-q07aRYVYtbmsnkK0zvZ9mewiUuwO0CY1dopzjFXEyLXSiJoyXhucBIpS5ZG8G7Y2WLWde0oVv2ZvR0KtEMR7FDwCPaGzS96D24KnnuKGtM9FsHr5Wf0PU-oqMrWcz8G0a5kWS4jeN4Zbfk7REIiFUkcwfvBiqvJ_72W3f8b_gq2vh6Niy8nZ6cv4AFHwNWpivZgs72e230ETK1-Gc4oge937RS_AfBoIWg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+and+application+of+a+fully+automatic+multi-function+cassette+module+Mortenon+M1+for+radiopharmaceutical+synthesis&rft.jtitle=Annals+of+nuclear+medicine&rft.au=Cui%2C+Fang-Bo&rft.au=Lv%2C+Xuan&rft.au=Yan%2C+Cheng-Long&rft.au=Eng%2C+Wai-Si&rft.date=2024-04-01&rft.eissn=1864-6433&rft.volume=38&rft.issue=4&rft.spage=247&rft_id=info:doi/10.1007%2Fs12149-023-01893-2&rft_id=info%3Apmid%2F38145430&rft.externalDocID=38145430
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0914-7187&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0914-7187&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0914-7187&client=summon